Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL
Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL
Active, not recruiting · NCT03740334 · Registry updated 2026-08-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 1 | 2026-08-21 | NCT03740334 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dana-Farber Cancer Institute | 324 |
| Novartis | 114 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Boston Children's Hospital | Boston | United States | 343 |
| Children's Healthcare of Atlanta | Atlanta | United States | 47 |
| Children's Hospital Colorado | Aurora | United States | 312 |
| Children's Hospital of Philadelphia | Philadelphia | United States | 434 |
| Children's Hospital of Wisconsin | Milwaukee | United States | 87 |
| Cincinnati Children's Hospital Medical Center | Cincinnati | United States | 405 |
| Dana Farber Cancer Institute | Boston | United States | 300 |
| Dana-Farber Cancer Institute | Boston | United States | 626 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 2 |
| Nemours/Alfred I. duPont Hospital for Children | Wilmington | United States | 7 |
| Roswell Park Cancer Institute | Buffalo | United States | 382 |
| Texas Children's Hospital | Houston | United States | 187 |